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ABSTRACT
Fragmentsofprostaticacidphosphatase(PAP248 286)inhumansemendramatically
increase HIV infection eYciency by increasing virus adhesion to target cells.
PAP248 286 only enhances HIV infection in the form of amyloid aggregates termed
SEVI (Semen Enhancer of Viral Infection), however monomeric PAP248 286
aggregates very slowly in isolation. It has therefore been suggested that SEVI ﬁber
formation in vivo may be promoted by exogenous factors. We show here that a
bacterially-produced extracellular amyloid (curli or Csg) acts as a catalytic agent
for SEVI formation from PAP248 286 at low concentrations in vitro, producing
ﬁbers that retain the ability to enhance HIV (Human Immunodeﬁciency Virus)
infection. Kinetic analysis of the cross-seeding eVect shows an unusual pattern.
Cross-seeding PAP248 286 with curli only moderately aVects the nucleation rate
whilesigniﬁcantlyenhancingthegrowthofﬁbersfromexistingnuclei.Thispatternis
incontrasttomostpreviousobservationsofcross-seeding,whichshowcross-seeding
partiallybypassesthenucleationstepbuthaslittleeVectonﬁberelongation.Seeding
other amyloidogenic proteins (IAPP (islet amyloid polypeptide) and A1 40) with
curli showed varied results. Curli cross-seeding decreased the lag-time of IAPP
amyloid formation but strongly inhibited IAPP elongation. Curli cross-seeding
exerted a complicated concentration dependent eVect on A1 40 ﬁbrillogenesis
kinetics. Combined, these results suggest that the interaction of amyloidogenic
proteins with preformed ﬁbers of a diVerent type can take a variety of forms and
is not limited to epitaxial nucleation between proteins of similar sequence. The
ability of curli ﬁbers to interact with proteins of dissimilar sequences suggests
cross-seeding may be a more general phenomenon than previously supposed.
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Over 33 million people worldwide are currently infected with the HIV virus. While HIV
is readily transmitted in vivo, HIV is a surprisingly ineVective pathogen in vitro (Thomas,
Ott & Gorelick, 2007). The key barrier to eVective viral transmission is attachment to the
target cell surface. The short-half life of almost all viruses in solution (6 h for HIV)
ensures that infection can only be achieved only if a signiﬁcant number of viral particles
adhere to the cell surface in a relatively narrow time window upon exposure (Perelson et
al., 1996). A peptide fragment naturally occurring in human seminal ﬂuid (PAP248 286)
facilitates this ﬁrst step, and in doing so, greatly enhances the infectivity of HIV (Munch
et al., 2007). When ﬁbrillized into amyloid ﬁbers termed SEVI (Semen-derived Enhancer
of Virus Infection), (Munch et al., 2007; Arnold et al., 2012; Roan et al., 2011) PAP248 286
bridges the membranes of the HIV virion and target cells (Munch et al., 2007; Roan et
al., 2009; Roan et al., 2010; Wurm et al., 2010; Kim et al., 2010). The result is a dramatic
increaseintheinfectivityoftheHIVvirus.Whileupto100,000HIVvirionsarerequiredto
establish infection in the absence of SEVI amyloid ﬁbers, only 3 are needed in its presence
(Munchetal.,2007).
This enhancement is speciﬁcally linked to the SEVI amyloid conformation of
PAP248 286 as monomers of PAP248 286 have little eVect (Munch et al., 2007; Roan et
al., 2010; Capule et al., 2012; Olsen et al., 2010). Since PAP248 286 only enhances HIV
infection when in the aggregated SEVI amyloid form, molecules that initiate ﬁbrillization
ofPAP248 286 canindirectlyincreaseHIVinfectivity.Whileamyloidformationistypically
energetically favorable, the actual rate of formation can be very slow. Speciﬁcally, amyloid
formationisanucleation-dependentprocessinwhichaslowrate-limitingnucleationstep
is followed by the faster process of extension of the ﬁber from the nuclei. PAP248 286 is
subject to signiﬁcant proteolytic degradation in seminal plasma unless it is in the SEVI
amyloidform(Martellinietal.,2011).ThetotalproductionofSEVIisthereforeultimately
controlled by the rate of amyloidosis due to the proteolytic degradation of unﬁbrillized
PAP248 286. PAP248 286 is very slow to ﬁbrillize in the absence of shaking in vitro, (Ye
et al., 2009; Olsen et al., 2012) which suggests SEVI production will be very limited in
vivo. Nevertheless, the SEVI amyloid form is found in semen at concentrations of up to
35g=mL(Munch etal., 2007;Kim etal., 2010). Thisﬁnding suggestsadditional cofactors
may be present that accelerate SEVI formation from PAP248 286 before the PAP248 286
monomerisdegradedbythecell’sproteolyticmachinery(Olsenetal.,2012).
One set of likely cofactors are other cellular proteins, since the factors that drive
self-association of amyloidogenic proteins also tend to favor promiscuous binding to
a variety of other proteins (Olzscha et al., 2011; Manzoni et al., 2011). In particular,
amyloidogenic proteins frequently have the ability to cross-polymerize, that is amyloid
ﬁbers from one protein can catalyze the formation of amyloid ﬁbers from another amy-
loidogenic protein. Cross-seeding amyloid ﬁbrillogenesis in this manner can dramatically
enhance the kinetics of amyloid formation by providing preformed nuclei for further
aggregation. Furthermore, the ﬁnal amyloid ﬁber can in some cases takes on some of
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 2/19the characteristics of ﬁbers from the initial seeding amyloid protein (Dzwolak et al., 2005;
Fooetal.,2011;Cloeetal.,2011).
Amyloid nucleation is often considered a highly speciﬁc process dependent on a high
degree of similarity in both peptide sequence and ﬁber morphology between the seed
and the protein being nucleated. This conclusion has largely been motivated by research
on prion amyloid ﬁbers, where the inability of highly homologous prions to cross-seed
amyloid formation presents an inter-species barrier to prion transmission (Chien,
Weissman & DePace, 2004; Apostol et al., 2011). However, this view has recently been
challengedbytheobservationofeYcientcross-polymerizationbetweenseveralnon-prion
amyloid species (Yagi et al., 2005; Han, Weinreb & Lansbury, 1995; Westermark, Lundmark
& Westermark, 2009; Morales et al., 2010; O’Nuallain et al., 2004; Ma & Nussinov, 2012).
Seeds formed from amyloid ﬁbers of some non-homologous proteins can either reduce
or eliminate the lag-time of amyloid formation of another protein, (Yagi et al., 2005; Han,
Weinreb & Lansbury, 1995; Westermark, Lundmark & Westermark, 2009; Morales et al.,
2010; O’Nuallain et al., 2004; MacPhee & Dobson, 2000) although the phenomenon is not
universal and even single point mutations have been shown to disrupt cross-seeding in
some cases (O’Nuallain et al., 2004; Jarrett & Lansbury, 1992; Hinz, Gierasch & Ignatova,
2008; Rajan et al., 2001). Cross-seeding may also be asymmetric, with one protein able to
seedanotherbutnotbeseededbyit(Yuetal.,2012;Siddiquaetal.,2012).
The amyloids produced by many bacteria and fungi are of particular interest in
considering possible cross-seeding reactions with PAP248 286 because of the high
incidence of microbial infection in the vagina and the frequent coexistence with bacterial
and fungal infection with HIV infection (Thurman & Doncel, 2010). A particularly well
studied example is a highly amyloidogenic protein secreted by Escherichia coli (E. Coli)
andrelatedbacteria,CsgA,thatpolymerizesintocurliﬁbersthatareinvolvedincell-to-cell
andcell-to-surfaceinteractions(Jordaletal.,2009;Barnhart&Chapman,2006).Although
curliﬁbershavenottoourknowledgebeendirectlydetectedsofarinsemenorthevagina,
curli and curli-like amyloid ﬁbers are ubiquitous in mammalian hosts (Cegelski et al.,
2009). In fact, the innate immune response invoked by almost all amyloids has been
proposed to have evolved as a response to curli amyloid formation by E. Coli (Tukel et
al., 2009). Since functional amyloid ﬁbers from bacteria or yeast similar to curli may be
colocalized with PAP248 286 at the initial site of HIV infection, we tested the eVect of
preformed curli amyloid ﬁbrils on the kinetics of SEVI ﬁber formation. We found curli
does signiﬁcantly enhance the rate of SEVI ﬁbrillization, although through an unusual
mechanismforacross-seedinginteraction.
METHODS & MATERIALS
Peptide preparation
PAP248 286 wasobtainedfromBiomatikCorporation.TopreparemonomericPAP248 286,
lyophilized PAP248 286 was ﬁrst quickly dissolved in 20% acetic acid to a ﬁnal concen-
tration of 1 mg/ml to remove preformed aggregates. The aggregate free solution was then
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theassaybuVer(10mMphosphatebuVer,pH7.3containing150mMNaCl).
Human IAPP was obtained from Genscript. Monomeric IAPP was prepared by ﬁrst
dissolving in hexaﬂuoroisopropanol to a concentration of 1 mg/ml then lyophilizing
overnight. A1 40 was obtained from Anaspec. Monomeric A1 40 was prepared in
a similar way using 2% ammonium hydroxide instead of hexaﬂuoroisopropanol. The
lyophilizedpelletofbothpeptideswasdissolveddirectlyintheassaybuVer.
CsgA and CsgB preparation
CsgAandCsgBwereexpressed(Hammer,Schmidt&Chapman,2007)andpuriﬁed(Wang
et al., 2007) as previously described. Brieﬂy, both were overexpressed as His-tag fusion
proteins in LSR12 bacteria. Following centrifugation for 20 min at 5000  g, the bacterial
pellet was incubated in 8 M guanidine hydrochloride (from Sigma, adjusted to pH 7.2 by
the addition of NaOH) for 24 h with stirring. After incubation, the cells were centrifuged
again for 20 min at 10,000  g and the supernatant sonicated. The solution was then
passed over a HIS-SelectTM HF nickel-nitrilotriacetic acid column, washing ﬁrst with
50 mM KPi (pH 7.3) followed by 12.5 mM imidazole in 50 mM KPi (pH 7.3) to remove
non-speciﬁcally bound proteins and then with 125 mM imidazole in 50 mM KPi (pH 7.3)
toeluteCsgAorCsgB.
To prepare amyloid ﬁbers of CsgA and B, the curli containing fractions from the
HIS-SelectTM column allowed to ﬁbrillize overnight at room temperature. Protein
concentration wasmeasured bythe BCA (BicinchoninicAcid) assayprior to ﬁbrillization.
The resulting ﬁbers were then centrifuged (15 min at 10,000  g) and washed with water
to remove the imidazole salt. This procedure was repeated four times and the pellet
then lyophilized. The lyophilized pellets were then reconstituted in the assay buVer and
sonicated with a probe sonicator (Sonic Dismembrator Model 100, Fischer Scientiﬁc) for
approximately1minpriortotheaggregationassay.
Aggregation assays
Aggregation assays for PAP248 286 were performed in 10 mM phosphate buVer, pH 7.3
containing150mMNaCl.Atotalvolumeof40Lwasplacedineachwellofa96wellhalf
areaplatewithaclearbottom,with2mg/mLPAP248 286,25MThioﬂavinT,andeither0,
1,2.5,or5mol%preformedﬁbersofcurliAorB.AggregationassaysforIAPPandA1 40
were performed similarly except diVerent concentrations of peptide (2:5 M of IAPP and
5 M A1 40) and CsgA and CsgB were used and the temperature for IAPP aggregation
was set to 25 C. Amyloid ﬁbers of A1 40 and IAPP were prepared by aggregation for 2
days at 37 C as detailed below and were sonicated for 1 min before loading onto the plate
fortheseedingexperiments.
A single 1 mm glass bead was placed in each well to increase the aggregation rate and
promote sample reproducibility (Giehm & Otzen, 2010). The loaded plate was sealed,
and placed on a BioTek Synergy 2 plate reader set at 37 C (PAP248 286 and A1 40) or
25 C(IAPP)withaconstantlinearshakingspeedof17Hz.Absorbancewasmonitoredat
350nmandTHTﬂuorescencemeasurementsweretakenwithanexcitationﬁlterat440nm
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Data points were collected every 10 min, with continual shaking occurring between data
points.Allexperimentswereperformedwithsamplesintriplicate.Thekineticcurveswere
ﬁtted to a sigmoidal growth model that has empirically been found to reproduce most of
thefeaturesofamyloidaggregation:
I D
Imax  I0
1Ce.t t1=2/=k (1)
where I0 and Imax are the initial and maximum ﬂuorescence or absorbance values, t1=2 is
the time required to reach half intensity, and the elongation time te is an apparent ﬁrst
order time constant for the addition of peptide to existing ﬁbers (Naiki et al., 1991). The
lag-timet0 beforedetectableaggregationoccursisdescribedbyt0 D t1=2  2te.
Transmission electron microscopy
Samples of 6 L of PAP248 286 solutions after the aggregation experiment were applied to
200meshcarboncoatedcopperelectronmicroscopygridsandallowedtostandfor2min.
The grids were then washed with water 20 times to remove salts, after which 6 L of a 2%
uranylacetatesolutionwasaddedandallowedtosetfor1minbeforebeingremoved.Fiber
images were taken on a Phillips X-100 Transmission Electron Microscope operating at
60kVand10,500magniﬁcation.
Cells for infectivity assays
A CEM-GFP cell line that expresses a green ﬂuorescent protein (GFP) driven by the
HIV-1 LTR promoter was obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH from Dr. Jacques Corbeil and maintained
in RPMI1640 (Invitrogen) medium supplemented with 10% heat-inactivated fetal
bovine serum (HyClone) (RPMI-10) and containing 500 g=ml geneticin (Invitrogen)
(Gervaixetal.,1997).
Infectivity assays
Infectivity assays were performed as previously described (Ono, Monde & Chukkapalli,
2011). A viral stock solution was prepared by transfection of HeLa cells with a HIV-1
molecular clone pNL4-3. Supernatants of transfected cells were collected 2 days post-
transfection, and viruses in the supernatant solution were pelleted by ultracentrifugation
and resuspended in RPMI-10 medium. These virus stocks (20,000 cpm RT activity) were
combined with stock solutions of SEVI amyloid ﬁbers (50 g=ml from a stock solution
of 440 M PAP248 286 incubated under aseptic conditions for 7 days at 37 C under
vigorous agitation (1300 rpm)) and used to inoculate 2  105 of CEM-GFP in 100 l
RPMI-10for2hat37 C.Cellswerethenwashedandincubatedin1mlRPMI-10at37 C.
Inoculationswereperformedintriplicate.Toblockthesecondroundofinfection,theCD4
blocking antibody Leu3a (0:25 g=ml) (BD Biosciences) and the reverse transcriptase
inhibitor AZT (1 M) (Sigma) were added to the medium 12 h post-infection. Two
days post-infection, cells were ﬁxed in 4% paraformaldehyde in PBS (phosphate buVer
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 5/19Figure 1 Kinetics of SEVI amyloid ﬁber formation in the presence of preformed ﬁbers of CsgA
and CsgB. Top: Turbidity measurements at 350 nm (A) PAP248 286C CsgA, (B) PAP248 286C CsgB.
Bottom: ThT ﬂuorescence measurements of (C) PAP248 286C CsgA, (D) PAP248 286C Csg B. Curves
are averages for 3 measurements.
saline)andanalyzedusingaFACSCantoﬂowcytometerandtheFlowJosoftwarever.8.7.1.
EYciencies of infection were determined directly from the percentage of GFP positive
cells after subtraction of the baseline activity obtained in the absence of HIV-1NL4 3.
Comparisonsbetweensamplesweremadeusingaone-tailedunpairedStudentt-test.
RESULTS
Seeding with curli ﬁbers greatly increases the rate of SEVI forma-
tion from PAP248 286
To test the in vitro activity of curli on the kinetics of SEVI amyloid formation from
PAP248 286, we measured the kinetics of amyloid formation and aggregation of 440 M
PAP248 286 solutions in the presence of curli nuclei (Giehm & Otzen, 2010). The curli
amyloidﬁberisactuallyacompositeofseveralproteins,(Barnhart&Chapman,2006)with
CsgAservingasthemainstructuralscaVoldandCsgBnucleatingamyloidformationfrom
CsgA(sequencesgiveninFig.S1)(Wang,Hammer&Chapman,2008).
PAP248 286 aggregated slowly in the absence of preformed nuclei of any type under
the conditions tested (Olsen et al., 2012), as shown by both turbidity measurements (a
nonspeciﬁc indicator of general aggregation, Figs. 1C and 1D) and ThT ﬂuorescence (a
measurement speciﬁc for amyloid, Figs. 1A and 1B). The lag time of formation (60 h) is
considerably longer than that previously described (18 h), (Munch et al., 2007; Ye et al.,
2009)atanidenticalconcentration,mostlikelyduetoadiVerenceinshakingspeedorionic
strength(Olsenetal.,2012).
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 6/19Figure 2 Elongation of SEVI amyloid ﬁbers is signiﬁcantly enhanced by preformed ﬁbers of CsgA
and CsgB lag time is less aVected. Impact of preformed curli A and B ﬁbers on the lag time (A and C)
and elongation time (B and D) of SEVI formation. (A and B): Kinetic constants as determined by ThT
ﬂuorescence.(CandD):Kineticconstantsasdeterminedbyturbiditymeasurements.Errorbarsrepresent
S.E.M.
Turbidity increased before ThT ﬂuorescence for samples without CsgA or CsgB
(Fig. 1). In addition, while the changes in turbidity could be closely approximated by
a sigmoidal curve for all samples, analysis of the residuals from the sigmoidal ﬁt to the
ThT ﬂuorescence shows two additional features not present in the turbidity curves.
First, a second early component with a short lag time (about 18 h, similar to previous
observations (Munch et al., 2007; Ye et al., 2009)) but low ThT ﬂuorescence (about 1=8
of the ﬁnal value) can be detected in the ThT measurements. Second, ThT ﬂuorescence
immediately decreases after the addition of high concentrations of CsgA. These ﬁndings
suggest amyloid formation by PAP248 286 may be a multistep process in which either
the formation of non-amyloid preﬁbrillar aggregates occurs before amyloid formation
for these samples (Suzuki et al., 2012; Horvath et al., 2012) or bundling of amyloid-like
protoﬁbrillar ﬁlaments is necessary for ThT binding to SEVI, as has been observed for
otheramyloidogenicproteins(Cabaleiro-Lagoetal.,2010).
The addition of preformed CsgA seed had a dramatic impact on the kinetics of
SEVI amyloid formation. One mol% CsgA (relative to PAP248 286) was suYcient to
cause a six-fold decrease in the elongation time constant, which is reﬂective of the
time for the addition of PAP248 286 to existing ﬁbers (Fig. 2B). CsgA seeds had only
a minor eVect on the lag time (Figs. 2A and 2C). This is an unexpected result, as the
addition of seeds usually results in the reduction or elimination of the lag-time with
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 7/19Figure 3 Curli nucleation produces longer SEVI ﬁbers. Top: TEM images of SEVI ﬁbers formed in the
absence of curli (A) and in the presence of 5 mol% CsgA (B) and CsgB (C) ﬁbers. Bottom: TEM images
of CsgA (D) and CsgB (E) ﬁbers. (F) Aspect ratios of individual ﬁbers grown with and without curli
nucleation (n D 47, 23 and 37 for SEVI, SEVIC CsgA, and SEVIC CsgB respectively). Fibers were grown
at a concentration of 440 M PAP248 286 at 37 C under 1400 rpm orbital shaking for 7 days. P values
were determined using a two-tailed unpaired Student t-test against the control sample.
little corresponding change in the rate of addition to pre-existing ﬁbers (Yagi et al.,
2005). CsgB has qualitatively similar eVects as CsgA on the kinetics of SEVI amyloid
formation, however the magnitude of the eVect is relatively less in comparison to CsgA
(Figs.1and2).
The diVerence in elongation rates for Csg initiated PAP248 286 ﬁber formation is
reﬂected in the morphology of individual ﬁbers. Fibers samples initiated by curli and
those grown in their absence are morphologically similar, except for a large diVerence
in the aspect ratios (Figs. 3A–3C and Fig. S2). Standard SEVI ﬁbers have an aspect ratio
of approximately 5.8, while those grown with CsgA and CsgB are more heterogeneous
and much longer, with aspect ratios of approximately 14.7 and 10.8 respectively (Fig. 3F
and Fig. S2). This ﬁnding is in agreement with the greatly enhanced ﬁber elongation rate
found in the presence of either of the curli ﬁbers. The very short and broken ﬁbers of all
PAP248 286 samples are diVerent than typical amyloid ﬁbers, such as the CsgA and CsgB
ﬁbers formed under quiescent conditions (Figs. 3D and 3E), most likely because the high
degreeofagitationrequiredforSEVIﬁberformationfragmentsnascentamyloidﬁbers.
SEVI amyloid ﬁbers obtained from curli nucleation retain the abil-
ity to enhance HIV infection
We next conﬁrmed that curli nucleated SEVI ﬁber samples retain a similar ability to
promote HIV infection as SEVI ﬁbers generated de novo. The activity of the SEVI ﬁbrils
incubated with Csg was tested using an infectivity assay in which a reporter T cell line
that expresses GFP upon HIV infection was used (Gervaix et al., 1997). In the absence
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 8/19Figure 4 Curli nucleated SEVI ﬁbers enhance HIV infectivity to a similar degree as SEVI generated
de novo. CEM-GFP cells were infected with HIV-1NL4 3 (20,000 cpm RT activity) supplemented either
with 50 g=ml oftheproteins indicated orPBS(phosphatebuVeredsaline).SEVI sampleswereﬁbrillized
for 7 days prior to infection. Measurements were performed in triplicate, error bars indicate S.E.M. P
values were determined using a two-tailed unpaired Student t-test against the control sample.
of SEVI, ﬂow cytometry showed a low percentage of GFP-positive cells, in agreement
with the low infectivity of HIV under the conditions employed. The addition of SEVI
ﬁbrils generated de novo caused an approximately 8-fold increase in the infectivity
(Fig. 4), roughly matching results of other studies of SEVI under conditions of high viral
load (Roan et al., 2009; Roan et al., 2010; Hauber et al., 2009). The much larger degree of
enhancement shown in some studies (>100,000 times) is only apparent at very high viral
dilution (Munch et al., 2007). Neither the PAP248 286 monomer nor equivalent amounts
of CsgA or CsgB alone had an eVect on HIV infection eYciency (Fig. 4). On the other
hand, CsgA and CsgB nucleated ﬁbers enhanced HIV infection at least to the same extent
as de novo generated SEVI ﬁbers (13 and 16 times respectively, Fig. 4). From these results,
it can be seen that the SEVI ﬁber samples, regardless of how they were nucleated, show a
comparableabilitytoenhancetherateofHIVinfection.
Cross-seeding with curli at low concentrations affects the amy-
loidogenesis of other proteins besides PAP248 286
The ability of curli to accelerate SEVI formation in the absence of any obvious sequence
similarity suggests curli may accelerate amyloid formation by other proteins as well. To
test this possibility, we performed analogous seeding experiments on the amyloidogenic
peptides IAPP and A1 40. Addition of preformed curli nuclei had a complex eVect on
the aggregation of both these peptides (Fig. 5 and Fig. S3). The ﬁbrillization rate of IAPP
was strongly decreased by low concentrations of both CsgA and Csg B (1% of the IAPP
concentration or 25 nM) (Fig. 5). Addition of CsgA, but not CsgB, to IAPP also lowered
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 9/19Figure 5 Curli’s ability to inﬂuence amyloid formation is not limited to PAP248 286. Impact of
preformed csgA and csgB ﬁbers on the lag time (A and C) and elongation time (B and D) of amyloid
formation from 2:5 M IAPP (top) and 5 M A1 40 (bottom) as molar fractions of the IAPP and
A1 40 concentrations.
the total ThT ﬂuorescence, suggesting either fewer or shorter ﬁbers are produced in the
presence of CsgA. The eVect of CsgA and CsgB on the ﬁbrillization rate of A1 40 was
more modest, and showed a more complex dependence on the concentration with the
ﬁbrillization rate slightly decreasing at lower concentrations and slightly increasing at
higher concentrations of both CsgA and CsgB (Fig. 5). The lag time of both peptides
decreased by approximately 50% after addition of 10 mol% of the oppositely charged
Csg protein (CsgA for IAPP and CsgB for A1 40), smaller amounts had little eVect.
Addition of 1% of the similarly charged Csg protein increased the lag time of both
peptides, surprisingly, larger amounts had little eVect on the lag time. By comparison,
additionofequivalentamountsofpreformedA1 40 ﬁbrilseedsledtoalineardecreasein
inductiontimebuthadlittleeVectontheﬁbrillizationrate(Fig.S4).Althoughacomplete
characterization of curli with IAPP and A1 40 lies outside the scope of this study, it
can be seen from these experiments that both the eVect of curli nucleation on amyloid
ﬁbrillogenesisisnotlimitedtoPAP248 286 andthatcurlicanserveasbothaninhibitorand
enhancerofﬁbrillization.
DISCUSSION
Inthisstudy,wecharacterizedthekineticsofPAP248 286 cross-seededbythecurliproteins
CsgA and CsgB in comparison to the analogous cross-seeding interactions with the more
amyloidogenic proteins hIAPP and A1 40. The purpose of this experiment is two-fold.
First,PAP248 286 isonlybiologicallyactiveintheSEVIamyloidﬁberform.Theproduction
of these ﬁbers is ultimately controlled by the rate of amyloidogenesis, as PAP248 286 is
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et al., 2011). Since SEVI ﬁbers have been detected in semen under conditions that
would apparently not easily allow aggregation in vitro of SEVI alone, (Munch et al.,
2007; Kim et al., 2010) extrinsic factors are a likely source to look for inﬂuences on
PAP248 286 aggregation. Second, amyloid cross-seeding as a general phenomenon is not
wellunderstood,asapparentlycontradictoryresultsregardingtheeYciencyandspeciﬁcity
of cross-seeding have been obtained (Yagi et al., 2005; Han, Weinreb & Lansbury, 1995;
Westermark, Lundmark & Westermark, 2009; Morales et al., 2010; O’Nuallain et al., 2004;
MacPhee&Dobson,2000;Jarrett&Lansbury,1992;Hinz,Gierasch&Ignatova,2008;Rajan
et al., 2001). In performing the cross-seeding of PAP248 286, we found that while the
lag-timeforamyloidformationismoderatelyaVectedbycurliseeding,theelongationrate
is greatly increased. This ﬁnding is novel for a cross-seeding reaction and is discussed in
moredepthbelow.
Anunderstandingofthisresultrequiressomeknowledgeofthebasicmechanismofthe
cross-seeding reaction. In epitaxial heteronucleation, growth occurs by speciﬁc structural
matchingoftheseedingnucleuswiththeproteinbeingseeded(Fig.6)(Apostoletal.,2011;
Wasmer et al., 2010). A greater understanding of this process can be made by considering
the structural constraints for amyloid formation. The cross -sheet structure common
to all amyloids is built by the intermolecular association of  sheets that are stabilized
by hydrogen bonds between amide backbone atoms of adjacent sheets. Since the amide
backbone, in contrast to the side-chain residues, is similar in all proteins, any unfolded
or partially folded protein should theoretically be able to associate with preformed seeds
of another to formed mixed ﬁbers. However, amyloid ﬁbers apparently derive much of
their energy from the formation of a “steric zipper”, in which the sidechains from adjacent
sheets from an interlocking dry surface (Apostol et al., 2011; Sawaya et al., 2007; Eisenberg
et al., 2011; Colletier et al., 2011). It can be seen from this requirement that epitaxial
heteronucleation is unlikely to occur if the seeding nucleus is structurally diVerent then
the protein being seeded, (Apostol et al., 2011; Wasmer et al., 2010; Wiltzius et al., 2009)
consistent with the observation that cross-seeding between amyloid proteins is most
eYcient when the two proteins have homologous sequences (Krebs et al., 2004). For most
amyloidogenic proteins this requirement is quite strict and even single point mutations
can eliminate the ability of one amyloidogenic protein to cross-seed another. For others,
the best studied being -synuclein which seeds a variety of non-homologous proteins,
this requirement is relaxed, possibly because the disorder present in the -synuclein’s
ﬁber structure can accommodate multiple ﬁber polymorphs and diVerent ﬁber interfaces
(Yagietal.,2005).
In the simplest model of epitaxially nucleated amyloidogenesis, the elongation time
decreaseslinearlywiththeconcentrationoftheseedaseachnewseedprovidesanewpoint
of ﬁbril growth (Padrick & Miranker, 2002; Cohen et al., 2011). However, the elongation
time is less sensitive to the seed concentration in more complicated models explicitly
considering secondary nucleation by fragmentation of existing ﬁbers, as the new ﬁbers
createdbyfragmentationprovideadditionalpointsforﬁbrilgrowththatcompetewiththe
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 11/19Figure 6 Cartoon models of possible cross-seeding reactions. Top: Epitaxial Heteronucleation
(A) Binding of the PAP248 286 monomer (red) to the curli seed (blue) induces formation of the
-sheet conformation of PAP248 286 (B) Fiber growth proceeds epitaxially from the seeding nucleus
Bottom: Possible mechanism for non-epitaxial heteronucleation (C) A nucleus for the SEVI ﬁber forms
independently of the curli ﬁber (D) Growth of the SEVI ﬁber initially proceeds slowly due to unfavorable
interactionsbetweensubunitsoftheﬁber(E)LateralattachmentofthenascentSEVIﬁbertocurlireduces
repulsion between ﬁber subunits thereby enhancing the rate of ﬁbrillogenesis. The curli seed may be
incorporated into the ﬁnal SEVI ﬁber or may detach to catalyze further ﬁber extension events.
nuclei from the original seeds (Cohen et al., 2011; Knowles et al., 2009). The maximal
elongation rate is in fact relatively insensitive to the seeding concentration when the
numberofnucleicreatedbyﬁbrilfragmentationismuchgreaterthanthenumberofnuclei
available from seeding (Cohen et al., 2011; Knowles et al., 2009). Such behavior is typically
observed experimentally (Yagi et al., 2005; Han, Weinreb & Lansbury, 1995; Padrick &
Miranker, 2002; Xue, Homans & Radford, 2008) and is seen here with the A1 40 protein
(see Fig. S4). Regardless of the exact quantitative expression, current models predict that
the lag-time for epitaxial heteronucleation should be more strongly aVected than the
elongationtime.
However,epitaxialheteronucleationisnottheonlypossiblemechanismbywhichcross-
seedingcanoccur.Incontrasttoepitaxialheteronucleation,non-speciﬁcheteronucleation
can aVect both the lag-time and the elongation rate by aVecting the stability of diVerent
species along the aggregation pathway or by lowering the surface tension associated
with forming clusters of the protein. In these mechanisms, the seed is not necessarily
incorporatedintothenewamyloidﬁber.Non-speciﬁcheteronucleationhasbeenproposed
for surfaces and non-protein ligands, (Pronchik et al., 2010; Auer, Trovato & Vendruscolo,
2009; Yin, Chen & Liu, 2009) but not to our knowledge for cross-seeding reactions with
other amyloidogenic proteins. Experiments with Lys to Ala PAP248 286 mutants show
that charge repulsion between monomer units destabilizes the amyloid ﬁber (Roan et al.,
2009). Lateral association of the curli ﬁber with the nascent PAP248 286 ﬁber can reduce
thisrepulsionbetweenmonomersubunits,increasingtheelongationratebutnotaVecting
the lag-time. In this case, it is expected that the electrostatic diVerences between CsgA
and CsgB ( 6 overall charge for CsgA and C5 for CsgB, PAP248 286 carries an overall
charge of C6) are primarily responsible for the diVerence in cross-seeding eYciencies,
although diVerences atomic-level diVerences in the packing between CsgA and CsgB and
Hartman et al. (2013), PeerJ, DOI 10.7717/peerj.5 12/19PAP248 286 may also play a role. It is important to note that a stable interaction between
thePAP248 286 amyloidﬁberandCsgAorCsgBmaynotberequired,astheoreticalstudies
showthatthestabilityofamyloidﬁbersincreaseswiththelengthoftheﬁber(Linse&Linse,
2011). A transient interaction of CsgA or CsgB with PAP248 286 may stabilize a short,
energetically unfavorable PAP248 286 ﬁber long enough to promote the formation of a
longerandmorestableamyloidﬁber.
The interaction of curli with IAPP and A1 40 is less clear. Electrostatics plays a role in
cross-seeding nucleation, as the oppositely charged curli protein reduces the lag-time of
both IAPP and A1 40 but the similarly charged curli protein has less eVect. Both CsgA
and CsgB decrease the elongation rate of IAPP, most likely by binding to and blocking
reactive ﬁbril ends. The eVect of CsgA and CsgB on the elongation rate of A1 40 has
a complex concentration dependence, likely the result of a mixture of stimulatory and
inhibitoryeVectspreviouslyobservedinthebindingofsomeligandstoamyloidpeptides.
Although the eVects of curli on A1 40 were moderate, cross-seeding between other
bacterial functional amyloids and A1 40 may have greater clinical signiﬁcance. For
example, the bacteria Borrelia burgdorferi produces a curli-like amyloid protein that
colocalizes with A amyloid deposits in Alzheimer’s patients (Miklossy, 2008; Miklossy et
al.,2004).Similarly,inoculationwithChlamydiapneumoniaestimulatestheproductionof
A1 42 amyloidplaques,(Gerardetal.,2006;Littleetal.,2004)althoughtoourknowledge
a curli-like amyloid protein has not been found yet for Chlamydia pneumonia. Although
a deﬁnitive link between bacterial infection and amyloid-associated neurodegenerative
diseases has been elusive due to the diYculties in ﬁrmly establishing bacterial infection
considering the low levels of bacteria typical of chronic long-term infections (Dobson,
Wozniak & Itzhaki, 2003) the identiﬁcation of new amyloidogenic proteins in bacteria
and mammals is increasing rapidly (Jordal et al., 2009) opening up the possibility of an
increasing role for bacterial and viral infections in poorly understood amyloidogenic
diseases.
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